196 related articles for article (PubMed ID: 38338867)
1. CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.
De Feo A; Manfredi M; Mancarella C; Maqueda JJ; De Giorgis V; Pignochino Y; Sciandra M; Cristalli C; Donadelli M; Scotlandi K
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338867
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation.
De Feo A; Sciandra M; Ferracin M; Felicetti F; Astolfi A; Pignochino Y; Picci P; Carè A; Scotlandi K
Cell Death Dis; 2019 Jun; 10(7):471. PubMed ID: 31209202
[TBL] [Abstract][Full Text] [Related]
3. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
[TBL] [Abstract][Full Text] [Related]
4. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Balestra T; Manara MC; Laginestra MA; Pasello M; De Feo A; Bassi C; Guerzoni C; Landuzzi L; Lollini PL; Donati DM; Negrini M; Magnani M; Scotlandi K
Mol Cancer Ther; 2022 Jan; 21(1):58-69. PubMed ID: 34667115
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.
Mancarella C; Giusti V; Caldoni G; Laginestra MA; Parra A; Toracchio L; Giordano G; Roncuzzi L; Piazzi M; Blalock W; Columbaro M; De Feo A; Scotlandi K
Cancer Gene Ther; 2023 Sep; 30(9):1285-1295. PubMed ID: 37353558
[TBL] [Abstract][Full Text] [Related]
6. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
[TBL] [Abstract][Full Text] [Related]
7. GDF6-CD99 Signaling Regulates Src and Ewing Sarcoma Growth.
Zhou F; Elzi DJ; Jayabal P; Ma X; Chiu YC; Chen Y; Blackman B; Weintraub ST; Houghton PJ; Shiio Y
Cell Rep; 2020 Nov; 33(5):108332. PubMed ID: 33147457
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
9. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC; Manferdini C; Cristalli C; Carrabotta M; Santi S; De Feo A; Caldoni G; Pasello M; Landuzzi L; Lollini PL; Salamanna F; Dominici S; Fiori V; Magnani M; Lisignoli G; Scotlandi K
Cancer Immunol Res; 2024 Feb; 12(2):247-260. PubMed ID: 38051221
[TBL] [Abstract][Full Text] [Related]
10. CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling.
Ventura S; Aryee DN; Felicetti F; De Feo A; Mancarella C; Manara MC; Picci P; Colombo MP; Kovar H; Carè A; Scotlandi K
Oncogene; 2016 Jul; 35(30):3944-54. PubMed ID: 26616853
[TBL] [Abstract][Full Text] [Related]
11. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
12. CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.
Martinelli M; Parra A; Scapoli L; De Sanctis P; Chiadini V; Hattinger C; Picci P; Zucchini C; Scotlandi K
Oncotarget; 2016 Nov; 7(47):77958-77967. PubMed ID: 27792997
[TBL] [Abstract][Full Text] [Related]
13. Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.
Gassmann H; Schneider K; Evdokimova V; Ruzanov P; Schober SJ; Xue B; von Heyking K; Thiede M; Richter GHS; Pfaffl MW; Noessner E; Stein LD; Sorensen PH; Burdach SEG; Thiel U
Cells; 2021 Aug; 10(8):. PubMed ID: 34440851
[TBL] [Abstract][Full Text] [Related]
14. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications.
Amaral AT; Manara MC; Berghuis D; Ordóñez JL; Biscuola M; Lopez-García MA; Osuna D; Lucarelli E; Alviano F; Lankester A; Scotlandi K; de Álava E
PLoS One; 2014; 9(2):e85814. PubMed ID: 24498265
[TBL] [Abstract][Full Text] [Related]
16. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
17.
Louati S; Senhaji N; Chbani L; Bennis S
Dis Markers; 2018; 2018():7971019. PubMed ID: 30319719
[TBL] [Abstract][Full Text] [Related]
18. EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma.
Jiménez JA; Apfelbaum AA; Hawkins AG; Svoboda LK; Kumar A; Ruiz RO; Garcia AX; Haarer E; Nwosu ZC; Bradin J; Purohit T; Chen D; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
Mol Cancer Res; 2021 Jul; 19(7):1182-1195. PubMed ID: 33741715
[TBL] [Abstract][Full Text] [Related]
19. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
[TBL] [Abstract][Full Text] [Related]
20. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.
Sankar S; Theisen ER; Bearss J; Mulvihill T; Hoffman LM; Sorna V; Beckerle MC; Sharma S; Lessnick SL
Clin Cancer Res; 2014 Sep; 20(17):4584-97. PubMed ID: 24963049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
